Riken Vitamin Management
Management criteria checks 2/4
Riken Vitamin's CEO is Kazuhiko Yamaki, appointed in Jun 2016, has a tenure of 8.67 years. directly owns 0.049% of the company’s shares, worth ¥35.09M. The average tenure of the management team and the board of directors is 4.1 years and 3.7 years respectively.
Key information
Kazuhiko Yamaki
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 8.7yrs |
CEO ownership | 0.05% |
Management average tenure | 4.1yrs |
Board average tenure | 3.7yrs |
Recent management updates
Recent updates
Riken Vitamin's (TSE:4526) Earnings Are Of Questionable Quality
Nov 21Riken Vitamin (TSE:4526) Will Pay A Dividend Of ¥40.50
Aug 28Riken Vitamin (TSE:4526) Has Announced A Dividend Of ¥40.50
Aug 13Riken Vitamin (TSE:4526) Will Pay A Dividend Of ¥40.50
Jul 26Riken Vitamin's (TSE:4526) Dividend Will Be ¥40.50
Jul 11Riken Vitamin's (TSE:4526) Promising Earnings May Rest On Soft Foundations
May 21Riken Vitamin (TSE:4526) Has Announced That It Will Be Increasing Its Dividend To ¥44.50
Mar 15Riken Vitamin (TSE:4526) Is Increasing Its Dividend To ¥44.50
Mar 01CEO
Kazuhiko Yamaki (65 yo)
8.7yrs
Tenure
Mr. Kazuhiko Yamaki serves as the President at Riken Vitamin Co., Ltd. since June 2016 and served as its Executive Officer since July 2006. Mr. Yamaki served as its Managing Director at Riken Vitamin Co.,...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President & Representative Director | 8.7yrs | no data | 0.049% ¥ 35.1m | |
Accounting Manager | no data | no data | no data | |
MD of Administrative | 1.7yrs | no data | 0.013% ¥ 9.4m | |
Executive Officer & GM of Human Resources Department | no data | no data | no data | |
Senior MD & Representative Director | 2.7yrs | no data | 0.033% ¥ 23.4m | |
MD of International Business Department & Director | 5.7yrs | no data | 0.013% ¥ 9.4m | |
Managing Executive Officer | 3.1yrs | no data | no data | |
Managing Executive Officer | no data | no data | no data | |
Managing Executive Officer & GM of Food Sales Division | 5.1yrs | no data | no data | |
Chief of PR & IR Office - Corporate Planning Department | no data | no data | no data | |
Head of Corporate Strategy & Director | no data | no data | 0.0033% ¥ 2.3m |
4.1yrs
Average Tenure
64yo
Average Age
Experienced Management: 4526's management team is considered experienced (4.1 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President & Representative Director | 14.7yrs | no data | 0.049% ¥ 35.1m | |
MD of Administrative | 2.7yrs | no data | 0.013% ¥ 9.4m | |
Senior MD & Representative Director | 12.7yrs | no data | 0.033% ¥ 23.4m | |
MD of International Business Department & Director | 2.7yrs | no data | 0.013% ¥ 9.4m | |
Head of Corporate Strategy & Director | 3.7yrs | no data | 0.0033% ¥ 2.3m | |
Director | 3.7yrs | no data | 0.020% ¥ 14.0m | |
Independent Outside Director | 7.7yrs | no data | 0.013% ¥ 9.4m | |
Independent External Director | 7.7yrs | no data | 0.0099% ¥ 7.0m | |
Independent Outside Director | 3.7yrs | no data | 0.0033% ¥ 2.3m | |
Independent Outside Director | 3.7yrs | no data | no data | |
Independent Outside Director | 1.7yrs | no data | no data |
3.7yrs
Average Tenure
65yo
Average Age
Experienced Board: 4526's board of directors are considered experienced (3.7 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/02/11 03:28 |
End of Day Share Price | 2025/02/10 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Riken Vitamin Co., Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
null null | Company Forecast |
null null | Daiwa Securities Co. Ltd. |
Yumiko Kai | Ichiyoshi Research Institute Inc. |